Evolve AMbiome^TM identifies and quantifies the millions of species of bacteria, fungi, and viruses in different mucosal environments of animals and humans for animal husbandry and clinical microbiome research applications.

With Evolve AMbiome^TM, you can:

• Improve animal health and productivity

• Develop new treatments for microbiome-related diseases

• Gain a better understanding of the human microbiome

• “Gut Microbiome Linked to Obesity, Diabetes, and Other Diseases” (The New York Times, 2015): https://www.nytimes.com/2019/09/10/well/eat/seeking-an-obesity-cure-researchers-turn-to-the-gut-microbiome.html

• “New Antibiotic Discovery Holds Promise for Combating Superbugs” (BBC News, 2016): https://www.bbc.com/news/health-46973641

• “Fecal Microbiome Transplants Show Promise for Treating Inflammatory Bowel Disease” (Reuters, 2017): https://pubmed.ncbi.nlm.nih.gov/35140783/

• Utilizes an unbiased DNA extraction method that captures DNA from most bacteria, fungi and protozoa

• Optimized DNA extraction method according to the sample type such as different swabs and stool specimens

• Utilizes sequencing information from variable regions covering over 90% of the 16S rRNA gene for bacterial diversity

• Utilize sequencing information from the Internal transcribed spacer (ITS) including ITS1 and ITS2 regions and other markers for fungi, mold and yeast diversity.

• A comprehensive panel of multiple genetic markers for detection of multiple agricultural pests and their vectors including the gut content of the vectors to ensure early disease detection for quick corrective action

• The generated analysis reports the detected microbial diversity at different taxonomic levels (Order, Family, Genus and Species levels)

• Min. sample required: Varies based on the sample type
  • Stool: 1-10g
  • Swab specimens: Nasal/buccal/genital swabs in UTM
• Turn-around time: 5-7 business days after the receipt of the samples